EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Strategies to Detect Chromosomal Anomalies Not Identified by NIPT

Fergus Scott iD, May Phoo Han, Ana Elizabeth Gomes de Melo Tavares Ferreira, James Elhindi, Andrew C McLennan iD

Prenatal Diagnosis · 2025-04 · 45 (4) · 464-472

DOI: 10.1002/pd.6755 ↗

At a glance

Journal article in Prenatal Diagnosis, published online on 2025-02-21. Written by Fergus Scott and 4 co-authors. Institution: Discipline of Women's Health, University of New South Wales, Randwick, Australia. Major MEDLINE topics: Noninvasive Prenatal Testing, Chromosome Aberrations, Chromosome Disorders. Cited 4 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Genome‐wide non‐invasive prenatal testing (gwNIPT) has screening limitations for detectable chromosomal conditions and cannot detect microdeletions/microduplications (MD) or triploidy. Thickened nuchal translucency (NT) only detects around 10% of these cases.

Methods

A 4‐year retrospective study of singleton pregnancies undergoing first‐line gwNIPT screening with subsequent CVS or amniocentesis. All MD cases, with or without gwNIPT screening, were also analyzed.

Results

Among 919 pregnancies with gwNIPT and invasive testing, 338 had a single chromosomal abnormality, with 9 false negative gwNIPT results (2.9%) and 26 undetectable abnormalities (18 MD, 8 triploidy) (7.7%). Twelve cases had a dual chromosomal abnormality and 4 returned a low‐risk gwNIPT result. Only three (9%) of the “missed cases” had a large NT and two of these also had a structural abnormality. Approximately 90% of chromosomal anomalies missed by gwNIPT were detected by invasive prenatal testing indicated by one or more of the following: failed NIPT (9%), low PAPP‐A (12%), early growth restriction (37%) and structural anomalies at pre‐NIPT, 13‐ or 20‐week ultrasounds (51%).

Conclusion

Most chromosomal abnormalities missed or unable to be found by gwNIPT are detected due to growth restriction or structural anomalies, not an enlarged NT. Failed NIPT and low PAPP‐A concentrations contributed to detection.

Subjects

MeSH terms (MEDLINE)

Noninvasive Prenatal TestingChromosome AberrationsChromosome DisordersHumansFemalePregnancyRetrospective StudiesAdultNuchal Translucency MeasurementAmniocentesis

Authors and institutions

  • Discipline of Women's Health, University of New South Wales, Randwick, Australia.
  • Sydney Ultrasound for Women, Sydney, Australia.
  • Women's and Newborn Health Department, Westmead, Australia.
  • Discipline of Obstetrics, Gynaecology and Neonatology, The University of Sydney, Camperdown, Australia.

ORCID profiles: Fergus Scott, Andrew C McLennan

Cite

APA

Scott, F., Han, M. P., Gomes de Melo Tavares Ferreira, A. E., Elhindi, J., & McLennan, A. C. (2025). Strategies to Detect Chromosomal Anomalies Not Identified by NIPT. Prenatal Diagnosis, 45(4), 464-472. https://doi.org/10.1002/pd.6755

Vancouver

Scott F, Han MP, Gomes de Melo Tavares Ferreira AE, Elhindi J, McLennan AC. Strategies to Detect Chromosomal Anomalies Not Identified by NIPT. Prenatal Diagnosis. 2025;45(4):464-472. doi:10.1002/pd.6755

BibTeX
@article{Scott2025,
  author = {Scott, Fergus and Han, May Phoo and Gomes de Melo Tavares Ferreira, Ana Elizabeth and Elhindi, James and McLennan, Andrew C},
  title = {Strategies to Detect Chromosomal Anomalies Not Identified by NIPT},
  journal = {Prenatal Diagnosis},
  year = {2025},
  volume = {45},
  number = {4},
  pages = {464--472},
  doi = {10.1002/pd.6755}
}
Start for free →